The role of peroxisome proliferator-activated receptor γ in blood pressure regulation

被引:0
作者
Milton Hamblin
Lin Chang
Jifeng Zhang
Y. Eugene Chen
机构
[1] University of Michigan Medical Center,Cardiovascular Center, Department of Internal Medicine
来源
Current Hypertension Reports | 2009年 / 11卷
关键词
Rosiglitazone; Pioglitazone; Telmisartan; Troglitazone; Blood Pressure Regulation;
D O I
暂无
中图分类号
学科分类号
摘要
Peroxisome proliferator-activated receptor-γ (PPARγ) is a member of the nuclear hormone receptor superfamily. It is expressed in adipocytes, immune cells, and cardiovascular cells that include cardiomyocytes, endothelial cells, and smooth muscle cells. PPARγ plays a role in regulating cellular anti-inflammatory responses and is a mediator of insulin sensitization induced by thiazolidinediones, which also can reduce elevated blood pressure both clinically and experimentally. As a result, research regarding the role of PPARγ in blood pressure homeostasis is ongoing. Recent studies have demonstrated that increases or decreases in blood pressure phenotype may be PPARγ-dependent and involve a number of different signaling pathways. Furthermore, studies using PPARγ mutant transgenic and knockout animal models provide further evidence regarding a role for endothelial-cell and vascular smooth muscle-cell PPARγ in blood pressure regulation. However, there is a need for further research regarding PPARγ- mediated mechanisms involved in maintaining physiologic control of blood pressure.
引用
收藏
页码:239 / 245
页数:6
相关论文
共 146 条
[1]  
Kliewer S.A.(1992)Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors Nature 358 771-774
[2]  
Umesono K.(2001)Peroxisome proliferator-activated receptor gamma and metabolic disease Annu Rev Biochem 70 341-367
[3]  
Noonan D.J.(1996)The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones J Med Chem 39 665-668
[4]  
Willson T.M.(1999)Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension Nature 402 880-883
[5]  
Lambert M.H.(2001)Increased expression of peroxisome proliferator-activated receptor-alpha and -gamma in blood vessels of spontaneously hypertensive rats Hypertension 38 249-254
[6]  
Kliewer S.A.(2005)Impaired expression of PPAR gamma protein contributes to the exaggerated growth of vascular smooth muscle cells in spontaneously hypertensive rats Life Sci 77 3037-3048
[7]  
Willson T.M.(1995)An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma) J Biol Chem 270 12953-12956
[8]  
Cobb J.E.(1999)Medical significance of peroxisome proliferator-activated receptors Lancet 354 141-148
[9]  
Cowan D.J.(1998)Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone Ann Intern Med 129 36-38
[10]  
Barroso I.(1993)Pioglitazone attenuates hypertension and inhibits growth of renal arteriolar smooth muscle in rats Am J Physiol Regul Integr Comp Physiol 265 R726-R732